Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-24 @ 7:55 PM
NCT ID:
NCT00026104
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed unresectable, locally advanced adenocarcinoma of the pancreas
* Residual disease after resection (R1 or R2, microscopic or macroscopic) allowed
* No metastases in major viscera
* No peritoneal seeding or ascites
* Biliary or gastroduodenal obstruction must have drainage before starting study therapy
* Radiographically assessable disease encompassable within a single irradiation field (15 by 15 cm maximum)
* Performance status - Zubrod 0-1
* Granulocyte count at least 1,800/mm\^3
* Platelet count at least 100,000/mm\^3
* ALT less than 3 times upper limit of normal
* Bilirubin less than 2.0 mg/dL
* Creatinine less than 3.0 mg/dL
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No other malignancy within the past 2 years except non-melanoma skin cancer or carcinoma in situ of the cervix, uterus, or bladder
* No significant infection or other medical condition that would preclude study
* No prior chemotherapy (including gemcitabine or paclitaxel) for pancreatic cancer
* No other concurrent cytotoxic agents
* See Disease Characteristics
* No prior radiotherapy to the planned field
* No other concurrent radiotherapy
* See Disease Characteristics
* No other concurrent investigational agents
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00026104
Study Brief:
Protocol Section:
NCT00026104